Clinical Trials Directory

Trials / Conditions / Pancreatic Cancer Stage IV

Pancreatic Cancer Stage IV

18 registered clinical trials studyying Pancreatic Cancer Stage IV — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingMesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
NCT07066995
Essen BiotechPhase 1 / Phase 2
WithdrawnEvaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cance
NCT06518538
Cornerstone PharmaceuticalsPhase 2
RecruitingThalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
NCT06017284
Fudan UniversityPhase 3
Active Not RecruitingPancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05642962
Memorial Sloan Kettering Cancer CenterPhase 1 / Phase 2
RecruitingStudy of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171
Panbela Therapeutics, Inc.Phase 2 / Phase 3
CompletedStudy of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer
NCT04953962
CanBas Co. Ltd.Phase 2
WithdrawnPanDox: Targeted Doxorubicin in Pancreatic Tumours
NCT04852367
University of OxfordPhase 1
UnknownA Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety o
NCT04674956
RenJi HospitalPhase 3
UnknownHeat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells
NCT04628806
Charite University, Berlin, Germany—
RecruitingSHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
NCT04150042
General Oncology, Inc.Phase 1
CompletedNivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer
NCT03697564
Hitendra PatelPhase 2
CompletedSHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Meta
NCT04181645
RenJi HospitalN/A
CompletedStudy of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
NCT03412799
Panbela Therapeutics, Inc.Phase 1
Active Not RecruitingPhase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.
NCT03252808
Takara Bio Inc.Phase 1
UnknownNonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer
NCT03236883
Tianjin Medical University Cancer Institute and HospitalPhase 1
UnknownIORT Versus CCRT for Pancreatic Cancer
NCT02981641
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/A
RecruitingThe Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
NCT04406831
Nuvance Health—
No Longer AvailableExpanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer
NCT04137822
Impatients N.V. trading as myTomorrows—